Nishin Bhadkamkar, MD
Department of General Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Professor, General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor (Joint appointment), Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX
Education & Training
Degree-Granting Education
| 2005 | Baylor College of Medicine, Houston, Texas, US, MD |
| 2001 | Rice University, Houston, Texas, US, Economics, BA |
Postgraduate Training
| 2014-2014 | Quality Improvement, Clinical Safety and Effectiveness Program, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2008-2011 | Clinical Fellowship, Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2005-2008 | Clinical Residency, Internal Medicine, Emory University School of Medicine, Atlanta, Georgia |
Licenses & Certifications
| 2011 | Medical Oncology Board Certification |
| 2011 | Texas Medical License |
| 2008 | Internal Medicine |
Experience & Service
Faculty Academic Appointments
Associate Professor, General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023
Associate Professor, Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023
Assistant Professor, Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2017
Assistant Professor, General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2017
Administrative Appointments/Responsibilities
Director of Education, Medical Oncology, Lyndon B. Johnson Hospital, Houston, Texas, 2024 - Present
Program Director ad interim, Hematology/Oncology Fellowship Program, Cancer Medicine, MD Anderson Cancer Center, Houston, TX, 2020 - 2024
Associate Program Director, Hematology/Oncology Fellowship Program, Cancer Medicine, MD Anderson Cancer Center, Houston, TX, 2019 - 2020
Director of Education, Hematology/Oncology Fellowship Program, MD Anderson Cancer Center, Houston, TX, 2016 - 2019
Director, Didactic Core Curriculum, Hematology/Oncology Fellowship Program, MD Anderson Cancer Center, Houston, TX, 2016 - 2024
Director of Education, Medical Oncology, Lyndon B. Johnson Hospital, Houston, TX, 2015 - 2020
Director, Medical Oncology Fund of Knowledge Exam, Hematology/Oncology Fellowship Program, MD Anderson Cancer Center, Houston, Texas, 2014 - 2024
Education Course Coordinator, Medical Oncology, Lyndon B. Johnson Hospital, Houston, TX, 2013 - 2015
Other Professional Positions
Faculty Consultant, GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2026 - Present
Program Co-Chair, General Oncology Grand Rounds, MD Anderson Cancer Center, Houston, TX, 2018 - 2023
Program Co-Chair, LBJ/MD Anderson Breast Tumor Board, Lyndon B. Johnson Hospital, Houston, TX, 2015 - 2020
Chair, Rectal Cancer Working Group, Lyndon B. Johnson Hospital, Houston, 2014 - 2017
Faculty Interviewer, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2013 - 2024
Faculty Adviser, Master Clinician Track, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2013 - 2020
Pathology Liaison, Medical Oncology, Lyndon B. Johnson Hospital, Houston, TX, 2012 - 2020
Program Chair, LBJ/MD Anderson GI/GU Tumor Board, Lyndon B. Johnson Hospital, Houston, TX, 2011 - 2020
Attending Faculty in Oncology Clinic, Lyndon B. Johnson Hospital, Houston, TX, 2011 - Present
Extramural Institutional Committee Activities
Member, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Formulary Management Escalation Team, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Clinical Competency Committee, Hematology/Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, 2024 - Present
Chair, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2024
Member, Hematology/Medical Oncology Board Review Planning Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Faculty Leader, Education Committee, Hematology/Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, 2019 - 2022
Vice Chair, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2021
Member, Faculty Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Chair, Clinical Competency Committee, Hematology/Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, 2017 - 2024
Member, Operational Priority Task Force for Education, The University of Texas MD Anderson Cancer Center, 2017 - 2018
Member, Executive Committee, Hematology/Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, 2016 - 2024
Member, Graduate Medical Education Curriculum Subcommittee, The University of Texas MD Anderson Cancer Center, 2016 - 2024
Member, Steering Committee, Hematology/Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, 2015 - 2024
General Oncology Representative, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2013 - 2019
Member, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2019
Member, Clinical Competency Committee, Hematology/Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, 2013 - 2017
Honors & Awards
| 2025 | Finalist, The Julie and Ben Rogers Award for Excellence in Education, MD Anderson Cancer Center |
| 2025 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2025 | Fellow of the American Society of Clinical Oncology (FASCO), American Society of Clinical Oncology |
| 2024 | Gerald P. Bodey Award for Excellence in Education, Division of Cancer Medicine, MD Anderson Cancer Center |
| 2022 | MD Anderson Distinguished Educator, MDACC Academy of Health Science Education |
| 2018 - 2019 | Education Scholars Program, American Society of Clinical Oncology |
| 2018 | President's Recognition for Faculty Excellence (Education and Mentorship Advancement), MD Anderson Cancer Center |
| 2018 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2017 | Emil J. Freireich Award for Excellence in Education, Department of Clinical Education, MD Anderson Cancer Center |
| 2017 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2017 | Leadership in Education Award, Division of Cancer Medicine, MD Anderson Cancer Center |
| 2016 | Teacher of the Year, MDACC Hematology/Oncology Fellowship Program |
| 2016 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2015 | Faculty Educator of the Month (July), MD Anderson Cancer Center |
| 2014 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2014 | Teacher of the Year, MDACC Hematology/Oncology Fellowship Program |
| 2013 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2012 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2011 | Educational Grant, Patricia Hodson Endowment Fund |
| 2010 | AACR/ASCO Workshop: Methods in Clinical Cancer Research, American Association for Cancer Research/American Society of Clinical Oncology |
| 2009 | Educational Grant, International Society of Gastrointestinal Oncology |
| 2003 | Honors in Basic Sciences, Baylor College of Medicine |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2022. Physician Panel Discussion (UNIV 330: Medical Exploration and Observorship). Invited. Rice University. Houston, TX, US.
- 2021. Physician Panel Discussion (UNIV 330: Medical Exploration and Observorship). Invited. Rice University. Houston, TX, US.
- 2021. Physician Panel Discussion (UNIV 330: Medical Exploration and Observorship). Invited. Rice University. Houston, TX, US.
- 2020. A Day in the Life of a Physician. Invited. Rice University. Houston, TX, US.
- 2020. Physician Panel Discussion (UNIV 330: Medical Exploration and Observorship). Invited. Rice University. Houston, TX, US.
- 2020. Physician Panel Discussion (UNIV 330: Medical Exploration and Observorship). Invited. Rice University. Houston, TX, US.
- 2019. A Day in the Life of a Physician. Invited. Rice University. Houston, TX, US.
- 2018. A Day in the Life of a Physician. Invited. Rice University. Houston, TX, US.
- 2017. A Day in the Life of a Physician. Invited. Rice University. Houston, TX, US.
- 2016. A Day in the Life of a Physician. Invited. Rice University. Houston, TX, US.
- 2016. The Path to Medicine. Invited. Rice University. Houston, TX, US.
- 2014. A Day in the Life of a Physician. Invited. Rice University. Houston, TX, US.
- 2013. Evolution of a Doctor. Invited. Rice University. Houston, TX, US.
- 2012. Medical School...What Is It Really Like?. Invited. Rice University. Houston, TX, US.
- 2011. Medical School...What Does It Really Take?. Invited. Rice University. Houston, TX, US.
National Presentations
- 2024. Non-Small Cell Lung Cancer. Invited. Advantage Program. Alexandria, VA, US.
- 2023. Non-Small Cell Lung Cancer. Invited. Advantage Program. Alexandria, VA, US.
- 2022. Recognizing and Optimizing Your Opportunities (Oncology Summer Internship Virtual Education Forum). Invited, US.
- 2022. Thriving During Training (Oncology Summer Internship Virtual Education Forum). Invited, US.
- 2022. Landing Your Dream Residency/Fellowship. Invited, US.
- 2021. A Day in the Life of an Oncologist: Overview of Oncology Subspecialties (Oncology Summer Internship Virtual Education Forum). Invited, US.
- 2021. COVID-19's Impact on Oncology Trainees (podcast). Invited. American Society of Clinical Oncology, US.
- 2020. The Impact of COVID-19 on Cancer Care/Oncology. Invited, US.
- 2020. Program Directors' Roundtable: The Impact of COVID-19 on Fellowship Training. Invited. ASCO (Virtual Education Program), US.
- 2014. Reducing the time from diagnosis to treatment of patients with stage II/III rectal cancer at a large county hospital. Invited. ASCO (Quality Care Symposium). Boston, MA, US.
- 2013. Outcomes in patients (pts) with colorectal cancer (CRC) treated with oxaliplatin-based chemotherapy (OC) following prior oxaliplatin exposure. Invited. ASCO (Gastrointestinal Cancers Symposium). San Francisco, CA, US.
Grant & Contract Support
| Date: | 2019 - 2024 |
| Title: | Supporting and Enhancing Caregiving for Individuals with Colorectal Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2018 - 2021 |
| Title: | Prevention of Hepatitis C Virus-Associated Second Primary Malignancies |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-Program Leader |
| Date: | 2015 - 2020 |
| Title: | Genome-Wide Association Study in Hepatocellular Carcinoma |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01CA186566 |
| Date: | 2014 - 2019 |
| Title: | The Hepatocellular Carcinoma Project |
| Funding Source: | MDACC Moon Shots Program |
| Role: | Co-I |
| Date: | 2014 - 2017 |
| Title: | Improving Coordination of Care and Education for Medically Underserved Patients Diagnosed with Colorectal Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| Date: | 2014 - 2017 |
| Title: | Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepatocellular Carcinoma |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP140518 |
| Date: | 2014 - 2019 |
| Title: | A Novel Tool for Predicting Response to Systemic Therapy in Patients with Hepatocellular Carcinoma |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01CA1760903 |
| Date: | 2013 - 2017 |
| Title: | Reducing Chemotherapy-Induced Neuropathy in CRC Patients Using Minocycline |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Co-PI |
| Date: | 2013 - 2015 |
| Title: | Improving Patient-Centered Outcomes in High-Risk Medically Disadvantaged Cancer Patients |
| Funding Source: | PCORI |
| Role: | Co-I |
| ID: | 45 |
| Title: | Correcting Disparities in Pancreatic Cancer Genomics Research |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
Selected Publications
Peer-Reviewed Articles
- Hutchings K, Al Zaki A, Bhadkamkar N, Willis J. Symptomatic pseudoprogression in metastatic colorectal cancer. BMJ Case Rep 17(6), 2024. e-Pub 2024. PMID: 38871645.
- Giuliani ME, Bhadkamkar NA, Giannopoulos E, Lubner S, Tseng J, Tibbits M, Von Roenn JH. Advancing the clinician educator career pathway in oncology. JCO Oncol Pract 19(5):e630-e638, 2023. e-Pub 2023. PMID: 36534924.
- Singhi EK, Dupuis MM, Ross JA, Rieber AG, Bhadkamkar NA. Medical Hematology/Oncology Fellows' Perceptions of Online Medical Education During the COVID-19 Pandemic. J Cancer Educ 35(5):1034-1040, 2020. e-Pub 2020. PMID: 32888144.
- Wang XS, Shi Q, Bhadkamkar NA, Cleeland CS, Garcia-Gonzalez A, Aguilar JR, Heijnen C, Eng C. Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial. J Pain Symptom Manage 58(4):662-671, 2019. e-Pub 2019. PMID: 31254639.
- Parkes A, Nusrat M, Di Tomasso PM, Davis L, Ogbonnaya S, Iwuorie M, Patel S, Abraham TG, Mack R, Bhadkamkar NA, Ma H, Nazario LA, Ramondetta L, Rosenstock A, Rieber AG. Successful Implementation of a Multidisciplinary Chemotherapy Efficiency Initiative at a Community Hospital. J Oncol Pract 15(6):JOP1800541, 2019. e-Pub 2019. PMID: 30990730.
- Ramsey SD, Unger JM, Baker LH, Little RF, Loomba R, Hwang JP, Chugh R, Konerman MA, Arnold K, Menter AR, Thomas E, Michels RM, Jorgensen CW, Burton GV, Bhadkamkar NA, Hershman DL. The Prevalence of Hepatitis B, Hepatitis C, and HIV Infection among Newly Diagnosed Cancer Patients Treated in Academic and Community Oncology Practices: SWOG S1204. JAMA Oncol 5(4):497-505, 2019. e-Pub 2019. PMID: 30653226.
- Unger JM, Hershman DL, Arnold KB, Loomba R, Chugh R, Hwang JP, O'Rourke MA, Bhadkamkar NA, Wang LX, Siegel AB, Cooley TP, Berenberg JL, Bridges BB, Ramsey SD. Stepwise Development of a Cancer Care Delivery Research Study to Evaluate the Prevalence of Virus Infections in Cancer Patients: SWOG S1204. Future Oncol 12(10):1219-31, 2016. e-Pub 2016. PMID: 26952901.
- Hoffmann MS, Leslie LA, Jacobs RW, Millas S, Surabhi V, Mok H, Jhaveri P, Kott MM, Jackson L, Rieber A, Bhadkamkar NA. Reducing the time from diagnosis to treatment of patients with stage II/III rectal cancer at a large public hospital. J Oncol Pract 12(2):e257-62, 2016. e-Pub 2016. PMID: 26869658.
- Sahin IH, Kazmi SM, Yorio JT, Bhadkamkar NA, Kee BK, Garrett CR. Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature. J Cancer 4(4):320-2, 2013. e-Pub 2013. PMID: 23569465.
- Garrett CR, George B, Viswanathan C, Bhadkamkar NA, Wen S, Baladandayuthapani V, You YN, Kopetz ES, Overman MJ, Kee BK, Eng C. Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary. Clin Colorectal Cancer 11(3):191-4, 2012. e-Pub 2012. PMID: 22280844.
- Garrett CR, Hassabo HM, Bhadkamkar NA, Wen S, Baladandayuthapani V, Kee BK, Eng C, Hassan MM. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer. Br J Cancer 106(8):1374-8, 2012. e-Pub 2012. PMID: 22421948.
- Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, Pisters LL. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol 167(1):65-70, 2002. e-Pub 2002. PMID: 11743277.
Invited Articles
- Rieber AG, McQuade JL, Bhadkamkar NA, Lopez G, Lee RT. Commentary on "Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis". Breast Diseases: A Year Book Quarterly 25(4):321-2, 2015. e-Pub 2015.
- Yorio JT, Bhadkamkar NA, Kee BK, Garrett CR. A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas. Int J Surg Oncol 2012:863034, 2012. e-Pub 2012. PMID: 22666572.
Review Articles
- Wo JY, Ashman JB, Bhadkamkar NA, Bradfield L, Chang DT, Hanna N, Hawkins M, Holtz M, Kim E, Kelly P, Ling DC, Olsen JR, Palta M, Raldow AC, Ruiz-Garcia E, Sheybani A, Stitzenberg KB, Das P. Radiation Therapy for Rectal Cancer: An ASTRO Clinical Practice Guideline Focused Update. Pract Radiat Oncol 15(2):124-143, 2024. e-Pub 2024. PMID: 39603501.
- Shah MA, Kennedy EB, Alarcon-Rozas AE, Alcindor T, Bartley AN, Malowany AB, Bhadkamkar NA, Deighton DC, Janjigian Y, Karippot A, Khan U, King DA, Klute K, Lacy J, Lee JJ, Mehta R, Mukherjee S, Nagarajan A, Park H, Saeed A, Semrad TJ, Shitara K, Smyth E, Uboha NV, Vincelli M, Wainberg Z, Rajdev L. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline. J Clin Oncol 41(7):1470-1491, 2023. e-Pub 2023. PMID: 36603169.
- Wo JY, Anker CJ, Ashman JB, Bhadkamkar NA, Bradfield L, Chang DT, Dorth J, Garcia-Aguilar J, Goff D, Jacqmin D, Kelly P, Newman NB, Olsen J, Raldow AC, Ruiz-Garcia E, Stitzenberg KB, Thomas CR, Wu QJ, Das P. Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol 11(1):13-25, 2021. e-Pub 2021. PMID: 33097436.
Other Articles
- Bhadkamkar NA How I Became a General Oncologist and Training Program Director. ASCO Connection, 2019.
Abstracts
- Bhadkamkar NA, Sahin IH, Shen Y, et al. Outcomes in patients (pts) with colorectal cancer (CRC) treated with oxaliplatin-based chemotherapy (OC) following prior oxaliplatin exposure. J Clin Oncol 31(4S):500, 2013. e-Pub 2013.
- Bhadkamkar NA, Kar SP, Weatherly J, et al. The role of multimodality therapy (MMT) in unresectable hilar cholangiocarcinoma (UHC) 29(15S):e14626, 2011. e-Pub 2011.
- Bhadkamkar NA, Javle MM, Wolff RA, et al. Osteoclastic giant cell tumor of the pancreas: a distinct clinical and pathologic entity 28(15S):e14648, 2010. e-Pub 2010.
Book Chapters
- Uemura M, Krishnan S, Kaseb AO, Bhadkamkar NA, Javle MM, Avritscher RA. Hepatocellular Carcinoma. In: The MD Anderson Manual of Medical Oncology. 3rd ed. McGraw-Hill, 2016.
- Bhadkamkar NA, Crane CH, Rodriguez-Bigas MA, Kopetz S, Eng C. Colorectal Cancer. In: The MD Anderson Manual of Medical Oncology. 2nd ed. McGraw-Hill, 2011.
- Bhadkamkar NA, Javle MM, Avritscher R, Krishnan S, Kaseb AO. Hepatobiliary Malignancies. In: The MD Anderson Manual of Medical Oncology. 2nd ed. McGraw-Hill, 2011.
- Bhadkamkar NA, Khuri FR. Retinoids and rexinoids in lung cancer. In: Lung Cancer. 3rd ed. Blackwell, 2007.
Patient Reviews
CV information above last modified July 22, 2026